Global Artificial Coma/Medically Induced Coma Market Report 2022, Featuring Profiles of Astrazeneca, Baxter Healthcare, Dr. Reddy's Laboratories, Fresenius and Piramal Healthcare
April 29, 2022 04:08 ET
|
Research and Markets
Dublin, April 29, 2022 (GLOBE NEWSWIRE) -- The "Global Artificial Coma/Medically Induced Coma Market Opportunity Analysis and Industry Forecast (by Drug Type, Application and Distribution Channel),...
Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)
April 28, 2022 09:05 ET
|
Clarus Therapeutics Holdings, Inc.
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Upon issuance, this patent will be...
Timber Pharmaceuticals Announces Fast Track Designation Granted by FDA for TMB-001 in Severe Subtypes of Congenital Ichthyosis
April 28, 2022 08:00 ET
|
Timber Pharmaceuticals
Company expects to launch pivotal Phase 3 ASCEND clinical trial to evaluate TMB-001 within the next 60 days BASKING RIDGE, NJ, April 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...
Clarus Therapeutics Announces Closing of Upsized $30.0 Million Underwritten Public Offering
April 27, 2022 13:43 ET
|
Clarus Therapeutics Holdings, Inc.
NORTHBROOK, Ill., April 27, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by...
Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022
April 26, 2022 16:10 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Sanofi: Informations relatives au nombre de droits de vote et d'actions – MARS 2022
April 26, 2022 14:28 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares – March 2022
April 26, 2022 14:28 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
North America Sports Medicine Market Expected to Generate a Revenue of $5,382 Million and Grow at a Healthy CAGR of 6.7% during the Forecast Timeframe from 2019 to 2025 [100-Pages] | Reveals by Research Dive
April 26, 2022 09:10 ET
|
Research Dive
New York, USA, April 26, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the North America sports medicine market is anticipated to garner $5,382 million in revenue and...
Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
April 26, 2022 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company, today announced it will report its first quarter 2022 financial results...
Europe Animal Healthcare Market revenue to surpass $49.4bn by 2027, says Graphical Research
April 26, 2022 03:12 ET
|
Graphical Research
Pune, India, April 26, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the Europe animal healthcare market is forecast to register its name in the...